Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bio-Path Holdings Q2 EPS $(0.55) Misses $(0.40) Estimate

Author: Benzinga Newsdesk | August 14, 2025 04:42pm
Bio-Path Holdings (OTC:BPTH) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.40) by 37.5 percent. This is a 52.59 percent increase over losses of $(1.16) per share from the same period last year.

Posted In: BPTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist